Summary
- HF Foods' stockholder rights plan - the kind of measure investors call a "poison pill" - was adopted in April 2023 with a stated 365-day expiration. It never went away.
- The company paid a $3.9 million SEC penalty in 2024 after regulators found executives concealed millions in liabilities and violated books-and-records rules. Former CEO Zhou Min Ni and former CFO Jonathan Ni both settled with the SEC.
- HFFG stock has fallen from a high of $34.81 to roughly $1.90 today - a 95% collapse that no operational turnaround has reversed.
- An activist investor holding 6.7% of shares filed a Schedule 13D/A in May 2026, signaling potential pressure on the board. A separate stockholder derivative suit is active in Delaware Chancery Court.
- I rate HF Foods (HFFG) as a Sell. The rights plan is not a governance feature. It is governance failure, formalized.
HF Foods adopted a "limited duration stockholder rights plan" on April 11, 2023. The press release called it a 365-day measure, expiring April 11, 2024. A poison pill - for those unfamiliar - is a corporate defense mechanism that makes a hostile takeover prohibitively expensive by issuing rights to existing shareholders that dilute any acquirer who crosses a set ownership threshold, typically 15%.
The word "limited" does a lot of persuasive work. It implies the measure was temporary, proportionate, and subject to board reconsideration. It was none of those things.
The rights plan has persisted. SEC filings confirm the company maintains the plan with a $19.50 exercise price and a 15% acquisition trigger - well over two years after it was supposed to expire. At a current share price of approximately $1.90, the existence of a $19.50 poison pill is almost comical: no acquirer at this valuation is the threat the board claims to be defending against. The real threat to HF Foods' directors is not a hostile bidder. It is accountability.
That being the case, the rights plan is not corporate governance. It is job protection for a board that presided over one of the more embarrassing fraud episodes in recent food distribution history.
In June 2024, the SEC charged HF Foods with violating the FCPA's books-and-records and internal-controls provisions. The company's former CEO Zhou Min Ni and former CFO Jonathan Ni were charged with concealing millions of dollars in liabilities and misappropriating investor funds. HF Foods settled with a $3.9 million penalty. Both former executives settled with the SEC as well.
When a company conceals liabilities on its balance sheet and the SEC is the entity uncovering them, the question for any investor is not whether the board deserves protection. It is whether the company deserves to continue operating at all.
The financials do nothing to rehabilitate the case. HF Foods generated full-year 2025 revenue of $1.23 billion. First quarter 2026 revenue grew 4.5% to $312 million, which management highlights as a sign of momentum. Adjusted EBITDA - earnings before interest, taxes, depreciation, and amortization, a rough proxy for operating cash generation - grew a marginal 3.8%. GAAP net income in Q1 2026 was $1.4 million on $312 million in revenue. That is a profit margin of roughly 0.45%. Free cash flow was negative $45,000 in Q1 2026.
I've been very surprised that any investor interprets a 0.45% profit margin and near-zero free cash flow as evidence of a turnaround. The company carries $163.3 million in total debt against $204.7 million in shareholder equity - a debt-to-equity ratio of 79.8%. It is barely solvent by equity standards, and it generates no meaningful cash to service that debt.
Now layer on the activist pressure. As of May 26, 2026, Zhou Min Ni - the former CEO who settled with the SEC - filed an amended Schedule 13D showing ownership of 3,559,397 shares, or 6.7% of the company. The filing described "past cooperation" with other shareholders. Simultaneously, a stockholder has sued HF Foods in Delaware Chancery Court, alleging the board's governance failures. A securities class action investigation by Kaskela Law was announced in April 2026.
The picture is structural, not cyclical. This is not a temporarily mispriced food distributor with a solid franchise and a rough quarter. This is a company that settled with the SEC for fraud, has not generated positive free cash flow, trades at 95% below its all-time high, and maintains a poison pill whose stated purpose has expired.
The false narrative here is that the rights plan represents prudent board defense. In my opinion, it represents the opposite: a board that knows it is on weak ground and is extending every available mechanism to stay in place. Companies that adopt poison pills to repel clearly undervaluation-based activist campaigns - like Broadcom in recent years - do so when the stock is strong, the franchise is valuable, and the board can credibly argue that short-term market pressure shouldn't override long-term strategy.
HF Foods has none of those conditions. The stock is already trading at pennies relative to its history. The franchise has been tarnished by a fraud settlement. The "long-term strategy" is a 0.45% profit margin.
Comparisons with companies that use poison pills defensively are not only unjustifiable; in my opinion, they are irresponsible. A poison pill makes sense when it preserves shareholder value by preventing a rushed, undervalued sale. At HF Foods, the pill is preserving board tenure while shareholder value has evaporated.
I rate HF Foods (HFFG) as a Sell. The combination of a persistent rights plan, a recent SEC fraud settlement, negative free cash flow, and mounting activist and litigation pressure creates a governance trap that no modest revenue growth can offset. In my opinion, the risk-reward is entirely unfavorable at $1.90 - and the rights plan is the signal that should tell any investor why.